Our site is undergoing maintenance. Search functionality may be intermittently unavailable. Thank you for your patience.
Next Generation Sequencing Discussion Tool
Biomarker testing through NGS technology has driven precision oncology by delivering faster, cheaper, and more accurate biomarker data. Results from NGS testing can help to diagnose cancer, personalize treatment, determine prognosis, or evaluate hereditary cancer risk. This nurse-patient discussion tool reviews common questions and answers to educate a patient about the biomarker testing process and what the results could mean for their treatment.
This resource was produced by ONS and sponsored by Foundation Medicine.
The ONS Biomarker Database was developed as a clinical decision support (CDS) tool to bring the most recent biomarker advances to the point of care.